Drug profile

The FDA adverse-event record for Flea Collar

270 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Flea Collar. See the species affected, top reactions, and outcomes below.

270
adverse-event reports
3.0%
death-coded share
Dog
most-reported species
107
Lack of efficacy (ectoparasite) - flea - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
270
Total Reports
8
Deaths Reported
3.0%
Death Rate

Active Ingredients

Flea Collar

Administration Routes

CutaneousTopicalUnknownOtherOralTransdermal

Species Affected

Dog 180
Cat 90

Most Affected Breeds

Domestic Shorthair 46
Chihuahua 31
Crossbred Canine/dog 23
Domestic Longhair 16
Cat (unknown) 10
Terrier - Yorkshire 9
Retriever - Labrador 9
Dog (unknown) 9
Shih Tzu 8
Dachshund (unspecified) 6

Most Reported Reactions

Lack of efficacy (ectoparasite) - flea 107
Lack of efficacy (flea) 60
Lethargy (see also Central nervous system depression in 'Neurological') 27
Scratching 21
Vomiting 16
Emesis 13
Itching 13
Underdose 12
Partial lack of efficacy 12
Panting 11
Vocalisation 11
Hyperactivity 10

Outcome Breakdown

Outcome Unknown
177 (65.6%)
Ongoing
43 (15.9%)
Recovered/Normal
34 (12.6%)
Died
8 (3.0%)
Recovered with Sequela
8 (3.0%)

Flea Collar Adverse Event Insights

270 reports name Flea Collar; 8 recorded a death outcome (3.0% of reported events, not a population-level mortality rate). Active ingredient: Flea Collar. Administration routes: Cutaneous, Topical, Unknown, Other.

By species: Dog (180 reports), Cat (90 reports). By breed: Domestic Shorthair (46), Chihuahua (31), Crossbred Canine/dog (23).

Leading clinical signs: Lack of efficacy (ectoparasite) - flea (107), Lack of efficacy (flea) (60), Lethargy (see also Central nervous system depression in 'Neurological') (27), Scratching (21). Outcome, 270 coded reports: Outcome Unknown leads at 65.6%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.